Evoke Pharma
EVOK
EVOK
25 hedge funds and large institutions have $7.83M invested in Evoke Pharma in 2021 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
17% less funds holding
Funds holding: 30 → 25 (-5)
50% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 10
Holders
25
Holding in Top 10
–
Calls
$1.54M
Puts
$155K
Top Buyers
| 1 | +$2.62M | |
| 2 | +$616K | |
| 3 | +$402K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$197K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$54.9K |
Top Sellers
| 1 | -$483K | |
| 2 | -$193K | |
| 3 | -$168K | |
| 4 |
CAN
Cetera Advisor Networks
El Segundo,
California
|
-$78K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$77K |